NCT01607762View on ClinicalTrials.gov

A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

October 31, 2012

Conditions
Healthy
Interventions
DRUG

Aripiprazole

Type= exact number, unit= mg, number= 5, form= tablet, route= oral administration. A single oral dose of a 5-mg aripiprazole tablet will be administered after an overnight fast.

DRUG

Quetiapine

Type= exact number, unit= mg, number= 100, form= tablet, route= oral administration. A single oral dose of two 50-mg quetiapine tablets will be administered after an overnight fast.

DRUG

Olanzapine

Type= exact number, unit= mg, number= 5, form= tablet, route= oral administration. A single oral dose of a 5-mg olanzapine tablet will be administered after an overnight fast.

DRUG

Risperidone

Type= exact number, unit= mg, number= 1, form= tablet, route= oral administration. A single oral dose of a 1-mg risperidone tablet will be administered after an overnight fast.

DRUG

Paliperidone

Type= exact number, unit= mg, number= 3, form= tablet, route= oral administration. A single oral dose of a 3-mg paliperidone tablet will be administered after an overnight fast.

Trial Locations (1)

Unknown

Merksem

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT01607762 - A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics | Biotech Hunter | Biotech Hunter